Myriad Genetics has broadened the scope of its MyRisk Hereditary Cancer Test for germline testing, adding genes.
The idea isn’t new. Big Tech has been trying for nearly two decades to revolutionise digital health records and patient data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback